Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2026 13:59 ET | Source: Robbins LLP

IBRX Investor Alert – ImmunityBio, Inc. Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action

Robbins LLP is Investigating Allegations that ImmunityBio, Inc. (IBRX) Misled Investors Regarding its Lead Product Candidate